Tailoring genomic services with custom QIAGEN workflows
GNOMIX established versatile tests for viral load, gene copy number variation, and more, finding limitless applications with dPCR.
Read more
Unlocking a real cure for HIV: Viral shock and kill therapy
While antiretroviral therapy (ART) has helped millions live healthy lives with HIV infection, HIV and AIDS burden health care systems and people continue to suffer from social stigma. But is a cure on the horizon?
Why save parasites from extinction?
A Korean biobank explains the importance of storing live parasite samples from around the world and how some species benefit us and our ecosystems.
A new climate for vector-borne diseases
Chagas disease has gained traction in North America and is fast becoming a pressing public health issue in impoverished communities. But health care researchers have a plan.
Predicting future outbreaks
One of the most promising tools to emerge from the pandemic is wastewater-based epidemiology (WBE). And public health experts are excited about its potential to detect a range of pathogen-related infections in the future.
Testing sewage to halt a pandemic
Early-warning surveillance is needed to help authorities continue their fight of COVID-19 and even prepare for future outbreaks. This is where wastewater testing comes in.
Guiding researchers with cutting edge dPCR technology
Clinical researchers are on a quest for medical breakthroughs. And fast. BioXpedia, a supporting lab is using digital PCR, the QIAcuity, to ensure accurate data from the unique samples they are given.
The future of gene doping and how to test for it
The evolution of Gene-doping, a new method of enhancing performance amongst athletes, and how one can test for it using PCR techniques.
Detecting microbial contamination
Microbiology lab built from the ground up using QIAGEN PCR technology to ensure valid results, cell line detection, and no contamination.
How oysters led to COVID-19 testing
I.A.G.E. analyze wastewater samples for COVID-19 through digital PCR (QIAcuity) to monitor outbreaks and target specific sequences identifying SARS-CoV-2 mutations.
Identifying the genetics behind obesity using dPCR
Digital PCR technology determines exact copy numbers from a single gene explaining why some individuals are prone to obesity.
dPCR. Standardized diagnostics from London to Shanghai.
Dr. Jim Huggett is using digital PCR to overcome one of the biggest challenges in diagnostics: how to standardize tests globally.
Identifying a rare bacterial infection in Brazil with the right diagnostic
A rare respiratory infection in São Paulo underscores the impact of molecular diagnostic tests in providing prompt and accurate treatment.
Will avian influenza become the next global pandemic?
Interview with public health expert, Julie Vaishampayan, on new emerging viral threats such as avian influenza.
Solving medical mysteries in the tropics
The unique case of a camper returning with a parasitic and bacterial co-infection and how molecular testing can improve these kinds of diagnoses.
Rome: Where surfing and syndromic testing collide
What do a surf camp for kids with special needs and the world of infectious diseases have in common? Not much except for an intrepid pediatrician with a passion for social issues.
Shifting gears in clinical testing
At the beginning of the COVID-19 pandemic, the first lab in Michigan to run PCR tests processed about 90 samples a day. By the time Omicron hit, it processed 2,700. But how did they manage keep up with testing needs? Especially when the nation faced massive shortages in testing kits?
Outrunning viruses with molecular tools
It is fascinating to think that a virus - an entity that can’t even carry out its own life cycle - can cause so much destruction. The question is how can labs continue to outpace the multitude of pathogens out there.
Why continued COVID-19 testing matters
As the nature of the pandemic has changed, and with promising COVID-19 treatments becoming available – it is difficult to decide when and how to use the different kinds of test available. How are labs deciding how to test? And why is continued testing so important?
Keeping thousands of passengers safe in floating cities
How do you ensure passenger safety on an enclosed ship? Especially when they number in the thousands. Costa Cruises has found a way.
Molecular testing in travel medicine
When lockdown began to ease in the UK, the creatives were on the front line to get back to work. But how can you test the hundreds of individuals that make up a film crew?
Quick pivot enables lab to serve community during pandemic
Great Lakes Labs president and CEO Michelle Volk redirected her lab’s focus from forensics to clinical medicine in reaction to the COVID-19 pandemic to provide her community with rapid, accurate testing, and peace of mind.
Avoiding repeat hospital visits with syndromic testing
The team at Mako Medical ensure fast test results to vulnerable senior communities, knowing that delays can present a real dilemma for patients with little time for diagnoses.
A new frontier for PCR testing
The NeuMoDx 288 Molecular System is tested in one of the largest medical labs in Eastern Germany.
Influenza or something else?
A new syndromic testing device, the QIAstat-Dx is cutting costs and saving time in the emergency room.
Battling infectious diseases
Geneva-based non-profit FIND, combats widespread poverty-related diseases with collaborative approaches to defeat new epidemic threats.
Fighting TB on The Last Frontier
Raising awareness and developing relationships with Alaskan authorities to help fight TB in rural and indigenous populations.
Radical thinking to eliminate TB in Indonesia
A Jakarta based pulmonologist explains the risks associated with TB and how individuals could protect the thousands of people around them.
The hidden TB epidemic in Ukraine
Tuberculosis (TB) physician Olha Konstantynovska describes what motivates her, how doctors overcome the extraordinary challenges of trying to provide desperately needed care in a war zone, and the implications for her country’s future.
Fighting the stigma. The key to eliminating TB.
Tuberculosis survivor and mycobacteriosis specialist uses QIAreach QuantiFERON-TB to test, treat and educate remote communities vulnerable to TB.
Fighting TB: Two countries, one disease, one solution
Tuberculosis does not discriminate. Two committed scientists separated by one vast ocean rely on molecular testing to quickly and automatically detect latent TB before it spreads to others in their communities.
Helping migrants start a new life without TB
Dr. Christian Herzmann, an expert in respiratory disease, is exploring creative ways to connect with a community susceptible to TB.
Treating latent TB in rural China
Fighting tuberculosis in rural china, with the third most cases of the infection worldwide, through testing and prevention.
Eradicating tuberculosis in hotspot regions
VTB’s impact is global, and can be transmitted to anyone around the world, rich or poor. But how are healthcare authorities in different hotspot regions combatting the disease?
Battling tuberculosis in the time of COVID-19
Dr. Story brings tuberculosis testing and treatment to susceptible homeless communities knowing that a disruption in TB testing during COVID would have major consequences.
Tuberculosis diagnosis turns patients into advocates
A trip to Africa set a couples’ life on a course they will never forget after contracting the world’s deadliest infectious disease.
Testing millions to stop tuberculosis migration
Why labor migration is an important factor in fighting against the world's deadliest infectious disease.
Making an impact in Africa
A task with a mission: helping the thousands of refugees and migrants dependent on fast and accurate latent TB results.
Misdiagnosed teacher's health scare unveils TB detection challenges
How a mystery ailment rattled a teacher and hundreds of students in Vermont.
Revisiting tuberculosis in an era of multi-resistant strains and dormancy challenges
The rise of multi-resistant strains of the most common chronic global infection demands new approaches in fighting the disease.
Like a smoldering ember that can catch fire again
How the leading TB assay can help tackle Japan’s high infection rates and the world’s top infectious disease killer.
Manipulating plant microbiomes for crop security
Manipulating plant microbiomes with beneficial soil bacteria helps combat parasitic weeds like Striga, reducing the need for herbicides.
Could the ancient oral microbiome be the key to improving modern health?
Researching ancient microbiomes to develop personalized oral microbiome transplants and improve systemic health.
Can the gut microbiome alleviate cancer treatment side effects?
Research on host-microbe interactions has come up with medicines to minimize toxicities associated with oncology therapies for cancer patients.
The future of immunity is in T cell mitochondria
A strong T-cell response defends against viral infections, autoimmune diseases, and unhealthy aging. The question is: how can we manipulate T cells to our advantage?
The mystery of missing red blood cells
More than 40% of the population in Southeast Asia has one of the genetic mutations responsible for the blood disorder thalassemia. But with so many blood disorders presenting similar symptoms, how can doctors give their patients diagnostic certainty?
What can Arctic microbes tell us about climate change?
Microbial ecologist, Stefan Thiele, travels to the most remote areas of the Arctic to study microbial communities in the ice. But what can these microbes tell us about climate change, now and in the future?
Identifying the world’s rarest coral
How we can genetically identify weaker corals before they die? One marine biologist is on mission to find out why some corals are more resilient to changes in our environment than others - At a cellular level.
Identifying bizarre samples using DNA sequencing data
Sequencing expert, Claire Griffin, continues to find new ways to identify the stranger side of nature by extracting DNA from bizarre tissue samples.
Using bacterial signatures to screen for colorectal cancers
The team at GoodGut develop an uninstructive alternative to current colorectal cancer diagnostic methods (which can often result in complications) using gut bacteria.
Saving biodiversity through DNA barcoding
Dr. Fontanilla guides conservation efforts to turn the tide on mass extinction and illegal wildlife trade using through DNA barcoding.
Using the human microbiome to decipher crime scene traces
Forensic investigators analyze genomes of human microorganisms to determine what took place at a crime scene.
Air microbiome provides answers to climate change
London researcher sequences invisible microbiome in air to understand why and how this ecosystem evolves.
Recovering RNA from miniscule samples
Using QIAGEN’s RNeasy Kit to purify quality RNA from colonic biopsies gaining insights to combat inflammatory bowel disease (IBD).
Molecular echos: the hidden microbiome left of the daily commute
Scientists around the world embark on an ambitious project to chart and better understand the microbiome on every surface.
Giving names to Ukraine’s missing
In a country torn apart by war, where does anyone start when it comes to identifying the thousands of missing persons?
How can you identify a person’s eye color from a heel bone?
How can you identify a person from only part of a found bone? Their skin, eye, or hair color? Especially when the bone is decades old.
Forensic answers left by silent victims
The team at DNA Labs International work with hundreds of law enforcement agencies, attorneys and government forensic labs to identify assailants who need to pay for their crimes and stopped from committing new ones.
Solving abandoned cold cases with molecular testing
A forensics lab overcomes the challenges of obtaining high quality DNA from ancient remains often associated with cold cases.
Deciphering RNA to solve impossible crime scenes
Forensic scientists are finding answers to almost impossible human ID cases with degraded and challenges samples through the help of RNA.
Explosive discoveries from trace DNA
Extracting seemingly impossible information from highly degraded touch DNA left on explosives and firearms with QIAGEN’s DNA extraction kits.
After the tsunami: Finding answers when loved ones go missing
A new NGS workflow allows identification of missing persons from the most difficult samples.
Looking to the future of missing persons analysis with NGS
Advanced DNA testing is revolutionizing the way we approach complex forensic challenges, offering new hope in solving missing persons cases.
Fighting AMR starts with chicken microbiota
Fighting AMR with alternatives to antimicrobial growth promotors in chicken gut microbiota.
Targeting the Achilles’ heel of tumors using molecular pathways
Not every cancer reacts the same way to a treatment. So why target all cells indiscriminately?
Analyzing the ancient origins of rare genetic diseases
Pushing the limits of genetic research in the study of rare disease in Turkey.
Neutralizing a bio-terrorist threat
Unraveling the mysterious pathways of a biodefense pathogen using IPA in the search for a therapeutic against dangerous arboviruses.
Revolutionizing cancer care: Next-gen diagnostic tests empower precision therapy
Marika Battarola's battle with ovarian cancer was transformed by next-generation diagnostic tests at a Milan hospital, where precise therapies were tailored to her tumor's specific mutations, dramatically enhancing her treatment and survival prospects.
The vital role of biomarker testing in early-stage NSCLC patients
Understanding the significance of NSLC biomarkers in lung cancer treatment in targeted therapies for improved patient care at all stages of disease.
New blood-based diagnostic tools for lung cancer
Targeting small RNA (sRNA) molecules vs. DNA as a diagnostic biomarker can assist oncologists in monitoring all stages of lung cancer while identifying patients for targeted immunotherapy.
Targeting sRNAs for a precise approach to liquid biopsy
Hummingbird Diagnostics teams up with QIAGEN to develop a unique lung cancer blood test showing what is happening in real-time.
Precision medicine for a neurological disease that can affect anyone
Neuron23 is finding a new approach to radically alter the progress of devastating neurodegenerative diseases like Parkinson’s. A disease that can affect anyone.
Hunting for traces of cancer in blood
Identifying prostate cancer patients who have stopped responding to first-line treatment. In real time. Now a possibility with liquid biopsy.
A life after the first successful pediatric CAR T-cell Therapy
How a father’s mission to cure his daughter of acute lymphoblastic leukemia set the trajectory to help fund innovative new cancer therapies to help hundreds of other children.
Sequencing COVID-19 mutations after jumping species
First there was a mink-associated COVID-19 strain outbreak. Then several countries reported variants in household pets. But Denmark had a plan to combat these potential vaccine escape mutants.
Faster cancer diagnoses using Artificial Intelligence
Japanese startup, PFDeNA, uses deep learning to quickly and accurately detect and diagnose different cancer types.
Treatments for patients on day one
NeoGenomics, the U.S.’s largest cancer diagnostic company set a precedent for the future of diagnostics by delivering a novel treatment to breast cancer patients on day one.
The immune system as medicine
Immune cells are manipulated to defend against cancer using QIAGEN’s next-generation sequencing technologies.
Attacking cancer from all angles
How QIAseq FastSelect helps pave the way towards more successful cancer treatment.
Diabetes linked to arsenic
Discovering the connection between environmental arsenic exposure and type II diabetes with QIAGEN Genomic Services.
Sequencing Singapore: Project SG10K and a vision for nationwide genomic analysis
Singapore's unique melting pot of ethnicities paves the way for tailored healthcare and pharmaceutical innovations, revolutionizing medicine through comprehensive genetic profiling.
Canine genetics key to advancing human eye disease treatment
Why are dogs pivotal in the study of human genetic diseases? Discover the insights gained from canine DNA research into the genetic roots of diseases shared by humans and their canine companions
Shaping personalized medicine's future
Explore the future of healthcare through the eyes of Dr. Richard K. Wilson. He imagines a world where smartphones are linked to affordable genome sequencing, which could offer early disease prediction for newborns and pioneer personalized medicine.
Read interview
Cracking the code - how RNA may hold the answer
Geneticists try to unravel the mysteries of RNA as it plays a vital role in regulating normal physiology.
Breaking the code - companion diagnostics
The benefits of companion diagnostics become clear at the Queen Elizabeth Hospital in Birmingham, England.